Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Other Non Operating Income (2020 - 2024)

Historic Other Non Operating Income for Silo Pharma (SILO) over the last 6 years, with Q3 2024 value amounting to -$2618.0.

  • Silo Pharma's Other Non Operating Income changed N/A to -$2618.0 in Q3 2024 from the same period last year, while for Dec 2024 it was -$14242.0, marking a year-over-year change of. This contributed to the annual value of -$14242.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2024, Silo Pharma's Other Non Operating Income stood at -$2618.0.
  • Silo Pharma's Other Non Operating Income's 5-year high stood at $427745.0 during Q4 2020, with a 5-year trough of -$198000.0 in Q2 2020.
  • For the 4-year period, Silo Pharma's Other Non Operating Income averaged around $41991.5, with its median value being $84.0 (2022).
  • As far as peak fluctuations go, Silo Pharma's Other Non Operating Income surged by 10963.74% in 2021, and later plummeted by 10148.31% in 2022.
  • Silo Pharma's Other Non Operating Income (Quarter) stood at $427745.0 in 2020, then plummeted by 77.21% to $97471.0 in 2021, then plummeted by 100.29% to -$283.0 in 2022, then tumbled by 825.09% to -$2618.0 in 2024.
  • Its Other Non Operating Income was -$2618.0 in Q3 2024, compared to -$2929.0 in Q2 2024 and -$8695.0 in Q1 2024.